Sanctuary Advisors’s West Pharmaceutical WST Stock Holding History

Sanctuary Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49M	Sell	4,155 -35	-0.8%	-$10.7K	0.01%	1204
2026 Q1	$1.05M	Sell	4,190 -700	-14%	-$174K	0.01%	1305
2025 Q4	$1.35M	Sell	4,890 -611	-11%	-$167K	0.01%	1157
2025 Q3	$1.44M	Buy	5,501 +20	+0.4%	+$4.86K	0.01%	1075
2025 Q2	$1.2M	Sell	5,481 -515	-9%	-$110K	0.01%	1115
2025 Q1	$1.34M	Buy	5,996 +189	+3%	+$52.1K	0.01%	989
2024 Q4	$2M	Sell	5,807 -993	-15%	-$313K	0.01%	859
2024 Q3	$2.15M	Buy	6,800 +3,042	+81%	+$932K	0.01%	832
2024 Q2	$1.35M	Buy	+3,758	New	+$1.33M	0.01%	1020

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Sanctuary Advisors's WST Position: Q2 2026 in Review

Sanctuary Advisors reduced its West Pharmaceutical (WST) stake by 0.84% in Q2 2026, selling an estimated $10.7K and leaving 4,155 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #1204.

Sanctuary Advisors first reported a position in WST in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.15M in Q3 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Sanctuary Advisors held 4,155 shares of West Pharmaceutical worth $1.49M as of Q2 2026.
Sanctuary Advisors sold 35 West Pharmaceutical shares in Q2 2026, an estimated $10.7K.
West Pharmaceutical made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1204 holding.
Sanctuary Advisors first reported a position in West Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
Sanctuary Advisors's West Pharmaceutical position peaked at $2.15M in Q3 2024.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.